IRIS

VIDALI, Matteo

VIDALI, Matteo  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16 1-gen-2006 Mondini, M; Vidali, Matteo; De Andrea, M; Azzimonti, Barbara; Airò, P; D'Ambrosio, R; Riboldi, P; Meroni, Pl; Albano, Emanuele; Shoenfeld, Y; Gariglio, Marisa; Landolfo, S.
An Observational Study of Venlafaxine and CYP2D6 in Clinical Practice. 1-gen-2014 Rolla, Roberta; Gramaglia, Carla Maria; Dalò, V; Ressico, F; Prosperini, P; Vidali, M; Meola, S; Pollarolo, P; Bellomo, Giorgio; E., Torre; Zeppegno, Patrizia
An observational study of Venlafaxine and CYP2D6 in clinical practice. 1-gen-2014 Rolla, Roberta; Gramaglia, C; Dalò, V; Ressico, F; Prosperini, P; Vidali, Matteo; Meola, S; Pollarolo, P; Bellomo, Giorgio; Torre, E; Zeppegno, Patrizia
Compliance, Adherence and Concordance Differently Predict the Improvement of Uremic and Microbial Toxins in Chronic Kidney Disease on Low Protein Diet 1-gen-2022 De Mauri, Andreana; Carrera, Deborah; Vidali, Matteo; Bagnati, Marco; Rolla, Roberta; Riso, Sergio; Torreggiani, Massimo; Chiarinotti, Doriana
Development of a method to measure plasma sorafenib concentration by liquid chromatography tandem mass spectrometry 1-gen-2011 Vidali, Matteo; Bagnati, M; Albertario, M; Atzeni, N; Scarano, D; Castellina, V; Viano, Ilario; Colangelo, Donato; Bellomo, Giorgio
Does Mediterranean Adequacy Index Correlate with Cardiovascular Events in Patients with Advanced Chronic Kidney Disease? An Exploratory Study 1-gen-2022 De Mauri, A.; Carrera, D.; Vidali, M.; Bagnati, M.; Rolla, R.; Riso, S.; Chiarinotti, D.; Torreggiani, M.
EVALUATION OF ANTIBIOTIC PROPHYLAXIS IN A CARDIOSURGERY UNIT 1-gen-2009 Vidali, Matteo; Bagnati, Marco; Colangelo, Donato; Basile, Matteo; Boieri, C; Viano, Ilario; Buongiorno, G; Teodori, G; Borre, S; Giuliani, Luigi; Bellomo, Giorgio
Genetic determinants of response to warfarin. 1-gen-2009 Rolla, R.; Meola, S.; Pollarolo, P.; Vidali, M.; Riccomagno, P.; Gaidano, G.; Bellomo, G.
Genetic determinants of response to warfarin. 1-gen-2009 Rolla, R.; Meola, S.; Pollarolo, P.; Vidali, M.; Riccomagno, P.; Gaidano, G.; Bellomo, G.
Genetic determinants of response to warfarin. 1-gen-2009 Rolla, R.; Meola, S.; Pollarolo, P.; Vidali, M.; Riccomagno, P.; Gaidano, G.; Bellomo, G.
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment 1-gen-2021 Boggio, E.; Gigliotti, C. L.; Moia, R.; Scotta, A.; Crespi, I.; Boggione, P.; De Paoli, L.; Deambrogi, C.; Garzaro, M.; Vidali, M.; Chiocchetti, A.; Stoppa, I.; Rolla, R.; Dianzani, C.; Monge, C.; Clemente, N.; Gaidano, G.; Dianzani, U.
La fosfolipasi A2 associata alle lipoproteine è un predittore indipendente di eventi cardiovascolari nei dializzati. 1-gen-2017 De Mauri, A.; Vidali, M.; Rolla, R.; David, P.; Brustia, M.; Ruva, C. E.; Bellomo, G.; Chiarinotti, D.
Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients 1-gen-2015 Rolla, Roberta; De Mauri, Andreana; Valsesia, Ambra; Vidali, Matteo; Chiarinotti, Doriana; Bellomo, Giorgio
Lipoprotein-associated phospholipase A2 predicts lower limb ischemia in hemodialysis subjects 1-gen-2019 De Mauri, A.; Vidali, M.; Chiarinotti, D.; Dianzani, U.; Rolla, R.
Polymorphisms associated with increased cardiovascular risk in the general population do not predict acute events in hemodialysis patients 1-gen-2016 Rolla, Roberta; De Mauri, Andreana; Vidali, Matteo; Valsesia, Ambra; Chiarinotti, Doriana; Bellomo, Giorgio
PREVALENCE OF AUTO-ANTIBODIES AGAINST CYTOCHROME P4502E1 IN ALCOHOLIC LIVER DISEASE 1-gen-2001 Vidali, Matteo; Rolla, Roberta; S., Stewart; E., Mottaran; D., Vay; M., Sartori; C., Rigamonti; C., Day; Albano, Emanuele
Probiotics-Supplemented Low-Protein Diet for Microbiota Modulation in Patients with Advanced Chronic Kidney Disease (ProLowCKD): Results from a Placebo-Controlled Randomized Trial 1-gen-2022 De Mauri, A.; Carrera, D.; Bagnati, M.; Rolla, R.; Chiarinotti, D.; Pane, M.; Amoruso, A.; Del Piano, M.; Vidali, M.
Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019 1-gen-2020 Rolla, R.; Vidali, M.; Puricelli, C.; Scotta, A. M.; Pedrinelli, A.; Pergolini, P.; Pirisi, M.; Dianzani, U.; Rigamonti, C.
Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism. 1-gen-2014 Rolla, Roberta; Pergolini, P; Vidali, Matteo; Pollarolo, P; Appiani, A; Cerutti, C; Manzini, M; Crisci, A; Bellomo, Giorgio
The Role of New Morphological Parameters Provided by the BC 6800 Plus Analyzer in the Early Diagnosis of Sepsis 1-gen-2024 Sacchetti, Sara; Vidali, Matteo; Esposito, Teresa; Zorzi, Stefano; Burgener, Alessia; Ciccarello, Lorenzo; Cammarota, Gianmaria; Zanotti, Valentina; Giacomini, Luca; Bellan, Mattia; Pirisi, Mario; Lopez, Ramon Simon; Dianzani, Umberto; Vaschetto, Rosanna; Rolla, Roberta